Get our Free Patent Expiration Newsletter

Serving leading biopharmaceutical companies globally:

Express Scripts
Mallinckrodt
Dow
Johnson and Johnson
McKesson
Moodys

Last Updated: October 23, 2019

DrugPatentWatch Database Preview

Drugs in Development Information for L-Lysine

See Plans and Pricing

« Back to Dashboard

Development status for investigational drug L-Lysine: Patents, clinical trial progress, indications

L-Lysine is an investigational drug.

There have been 13 clinical trials for L-Lysine. The most recent clinical trial was a Phase 3 trial, which was initiated on March 1st 2011.

The most common disease conditions in clinical trials are Syndrome, Leukemia, and Preleukemia. The leading clinical trial sponsors are National Cancer Institute (NCI), Roswell Park Cancer Institute, and Simbec Research.

There are two hundred and ten US patents protecting this investigational drug and one international patent.

Recent Clinical Trials for L-Lysine
TitleSponsorPhase
Nab-Paclitaxel and Durvalumab With or Without Neoantigen Vaccine in Treating Patients With Metastatic Triple Negative Breast CancerNational Cancer Institute (NCI)Phase 2
DEC-205/NY-ESO-1 Fusion Protein CDX-1401, Poly ICLC, Decitabine, and Nivolumab in Treating Patients With Myelodysplastic Syndrome or Acute Myeloid LeukemiaNational Cancer Institute (NCI)Phase 1
DEC-205/NY-ESO-1 Fusion Protein CDX-1401, Poly ICLC, Decitabine, and Nivolumab in Treating Patients With Myelodysplastic Syndrome or Acute Myeloid LeukemiaRoswell Park Cancer InstitutePhase 1

See all L-Lysine clinical trials

Clinical Trial Summary for L-Lysine

Top disease conditions for L-Lysine
Top clinical trial sponsors for L-Lysine

See all L-Lysine clinical trials

US Patents for L-Lysine

Drugname Patent Number Patent Title Patent Assignee Estimated Expiration
L-Lysine   Start Trial Acrylamidobenzoic acid derivatives and their use Sawai Pharmaceutical Co., Ltd. (Osaka, JP)   Start Trial
L-Lysine   Start Trial Novel peptidyl carbamate inhibitors of the enzyme elastase University of Kentucky Research Foundation (Lexington, KY)   Start Trial
L-Lysine   Start Trial Polymers of citric acid and diamines, a process for their preparation and their uses, in particular as carriers of drugs Sanofi (Paris, FR)   Start Trial
>Drugname >Patent Number >Patent Title >Patent Assignee >Estimated Expiration

Make Better Decisions: Try a trial or see plans & pricing

Serving leading biopharmaceutical companies globally:

Colorcon
McKinsey
Johnson and Johnson
AstraZeneca
Merck
Harvard Business School

Drugs may be covered by multiple patents or regulatory protections. All trademarks and applicant names are the property of their respective owners or licensors. Although great care is taken in the proper and correct provision of this service, thinkBiotech LLC does not accept any responsibility for possible consequences of errors or omissions in the provided data. The data presented herein is for information purposes only. There is no warranty that the data contained herein is error free. thinkBiotech performs no independent verifification of facts as provided by public sources nor are attempts made to provide legal or investing advice. Any reliance on data provided herein is done solely at the discretion of the user. Users of this service are advised to seek professional advice and independent confirmation before considering acting on any of the provided information. thinkBiotech LLC reserves the right to amend, extend or withdraw any part or all of the offered service without notice.